Danielle Boyle: Patient Voices Transform Progress in ITP Research and Care with ISTH
Danielle Boyle, Founder and CEO of ITP Australia and New Zealand, shared International Society on Thrombosis and Haemostasis (ISTH)’s post on LinkedIn, adding:
“I’m incredibly grateful to ISTH for sharing this member spotlight and for recognising the importance of patient voices in ITP research and care.
Founding ITP Australia and New Zealand has shown me, time and time again, that meaningful progress happens when patients, clinicians and researchers work together.
Lived experience brings context, clarity and humanity to the data, and it’s often the missing piece that helps shape research questions, treatment priorities and real ‑ world outcomes.
Hearing the stories, challenges and insights from people living with ITP is what drives this work forward.
Their voices don’t just inform research; they transform it.
Thank you to the International Society on Thrombosis and Haemostasis (ISTH) for highlighting the value of patient ‑ led organisations and for continuing to champion collaboration across the global haematology community.
I’m proud to be a member and part of a network that understands the power of partnership and the impact of listening deeply to the people at the heart of this condition.
- Grateful for the recognition.
- Grateful for the community.
- Grateful for the opportunity to keep pushing for better outcomes.”
International Society on Thrombosis and Haemostasis (ISTH) , shared a post on LinkedIn:
“Meet ISTH member Danielle Boyle, founder and CEO of ITP Australia and New Zealand.
In this video, she highlights the powerful role patient voices play in shaping meaningful research and improving outcomes for the ITP community.
We’re always so inspired to hear about the amazing work that our members are doing across the globe! ”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 28, 2026, 14:56Elizabeth Shirley: COVID-19 Vaccines, Spike Protein and Nitric Oxide Bioavailability
-
Oct 28, 2026, 14:39David Ledger: Anticoagulation Advances as Factor XIa Inhibition Reaches a New Milestone
-
Oct 28, 2026, 14:37Advancing Liver Health in Haemophilia Care – EAHAD
-
Oct 28, 2026, 14:34The Changing Landscape of Anticoagulant Therapy – ISTH
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters